Caveolin-1 Upregulation Contributes to c-Myc–Induced High-Grade Prostatic Intraepithelial Neoplasia and Prostate Cancer
- 1 February 2012
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 10 (2) , 218-229
Abstract
Previously we reported caveolin-1 (Cav-1) overexpression in prostate cancer cells and showed that it promotes prostate cancer progression. Here, we report that Cav-1 was overexpressed in 41.7% (15 of 36) of human high-grade prostatic intraepithelial neoplasia (HGPIN) specimens obtained during radical prostatectomies. Positive correlations exist between Cav-1–positive (Cav-1+) HGPIN and Cav-1+ primary prostate cancer (rho = 0.655, P < 0.0001) and between Cav-1 and c-Myc expression in HGPIN (rho = 0.41, P = 0.032). To determine whether Cav-1 cooperates with c-Myc in development of premalignant lesions and prostate cancer in vivo, we generated transgenic mice with c-Myc overexpression driven by the ARR2PB promoter. In this ARR2PB–c-myc model, Cav-1 overexpression was found in mouse PIN (mPIN) lesions and prostate cancer cells and was associated with a significantly higher ratio of proliferative to apoptotic labeling in mPIN lesions than in the Cav-1–negative epithelia adjacent to those lesions (10.02 vs. 4.34; P = 0.007). Cav-1 overexpression was also associated with increased levels of P-Akt and VEGF-A, which were previously associated with Cav-1–induced prostate cancer cell survival and positive feedback regulation of cellular Cav-1 levels, respectively. In multiple prostate cancer cell lines, Cav-1 protein (but not mRNA) was induced by c-Myc transfection, whereas VEGF siRNA transfection abrogated c-Myc–induced Cav-1 overexpression, suggesting a c-Myc–VEGF–Cav-1 signaling axis. Overall, our results suggest that Cav-1 is associated with c-Myc in the development of HGPIN and prostate cancer. Furthermore, Cav-1 overexpression in HGPIN is potentially a biomarker for early identification of patients who tend to develop Cav-1+ primary prostate cancer. Mol Cancer Res; 10(2); 218–29. ©2011 AACR.Keywords
All Related Versions
This publication has 40 references indexed in Scilit:
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- Caveolin-1 Promotes Autoregulatory, Akt-Mediated Induction of Cancer-Promoting Growth Factors in Prostate Cancer CellsMolecular Cancer Research, 2009
- Functional Analysis of Secreted Caveolin-1 in Mouse Models of Prostate Cancer ProgressionMolecular Cancer Research, 2009
- Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesisLaboratory Investigation, 2008
- N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastomaOncogene, 2008
- Combined c‐Myc and caveolin‐1 expression in human prostate carcinoma predicts prostate carcinoma progressionCancer, 2005
- Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotypeThe Prostate, 2004
- Myc regulates VEGF production in B cells by stimulating initiation of VEGF mRNA translationOncogene, 2004
- Epidermal growth factor inhibition of c-Myc-mediated apoptosis through Akt and Erk involves Bcl-xL upregulation in mammary epithelial cellsExperimental Cell Research, 2003
- The opposing roles of the Akt and c-Myc signalling pathways in survival from CD95-mediated apoptosisOncogene, 1998